Journal of Oral and Molecular Translational Medicine (JOMTM) is an international, peer-reviewed, open-access journal dedicated to the advancement of translational and interdisciplinary scholarship at the intersection of medicine and oral sciences. The journal publishes high-quality research that bridges the biological, clinical, and molecular dimensions of health as they pertain to both the oral cavity and the broader systemic environment.
The primary aims of the journal are to:
• Publish original research, systematic reviews, meta-analyses, clinical studies, and case reports that advance the understanding of oral-systemic disease relationships and their translational implications.
• Provide a dedicated scholarly platform for interdisciplinary research integrating medicine, dentistry, molecular pathology, immunology, oncology, microbiology, and precision medicine.
• Promote the translation of bench-to-bedside discoveries from molecular and cellular sciences into clinical diagnostic, prognostic, and therapeutic applications within oral and medical contexts.
• Foster global academic collaboration across institutions, specialties, and geographical regions, promoting diverse and internationally representative scholarship.
• Uphold the highest standards of publication ethics, editorial integrity, peer review rigour, and research transparency, in alignment with COPE, ICMJE, and DOAJ guidelines.
• Provide a structured pathway toward Scopus indexing and, subsequently, Web of Science inclusion, thereby amplifying the academic visibility and impact of published research.
Scope
The scope of Journal of Oral and Molecular Translational Medicine (JOMTM) encompasses the broad spectrum of biomedical and clinical disciplines in which oral and systemic sciences converge. The journal welcomes submissions from but is not limited to the following thematic domains:
1. Oral-Systemic Disease Relationships
• Associations between periodontal disease and systemic conditions including cardiovascular disease, diabetes mellitus, chronic kidney disease, rheumatoid arthritis, and adverse pregnancy outcomes.
• The role of oral microbiome dysbiosis in systemic inflammatory, metabolic, and autoimmune disease.
• Oral manifestations of systemic diseases and their diagnostic and prognostic significance.
2. Translational Medicine and Molecular Research
• Molecular mechanisms underlying oral and systemic disease pathogenesis.
• Biomarker discovery and validation for diagnostic, prognostic, and predictive applications in oral and medical oncology.
• Genomics, proteomics, transcriptomics, and epigenomics as applied to oral and systemic disease.
• Translational studies investigating novel therapeutic targets at the oral-systemic interface.
3. Oral Oncology and Head & Neck Medicine
• Oral and oropharyngeal carcinoma: pathogenesis, molecular profiling, HPV-related tumorigenesis, and precision therapeutic approaches.
• Head and neck surgical oncology and reconstructive medicine.
• Cancer immunology and immunotherapy as applied to oral and head and neck malignancies.
• Tumour microenvironment, tumour heterogeneity, and resistance mechanisms in oral cancers.
4. Diagnostic Pathology and Molecular Diagnostics
• Histopathological and cytopathological diagnosis of oral and systemic lesions.
• Application of immunohistochemistry, in situ hybridisation, fluorescence in situ hybridisation (FISH), and next-generation sequencing (NGS) in diagnostic pathology.
• Advances in digital pathology, artificial intelligence-assisted diagnostics, and computational pathology.
• Salivary diagnostics and liquid biopsy applications in oral and systemic disease.
5. Infectious Disease and Oral Microbiology
• Oral manifestations of viral, bacterial, fungal, and parasitic infections, including HIV/AIDS, COVID-19, and systemic mycoses.
• Oral microbiome characterisation, dysbiosis, and its relationship to local and systemic immune responses.
• Antimicrobial resistance patterns relevant to oral and maxillofacial infections.
6. Immunology and Inflammatory Disorders
• Immune-mediated oral mucosal diseases including pemphigus vulgaris, mucous membrane pemphigoid, lichen planus, and oral lupus.
• Innate and adaptive immune responses in oral infection and inflammation.
• Cytokine networks, toll-like receptor signalling, and inflammasome activation in periodontal and systemic disease.
7. Regenerative Medicine and Oral Tissue Engineering
• Stem cell biology and applications in oral and craniofacial tissue regeneration.
• Biomaterials science for oral implantology and bone regeneration.
• Growth factors, platelet-rich plasma (PRP), and scaffold-based approaches in periodontal and alveolar regeneration.
8. Pharmacology, Therapeutics, and Drug Delivery
• Systemic drug effects on oral tissues and the oral mucosa as a site for drug delivery.
• Pharmacological management of oral mucosal diseases and orofacial pain syndromes.
• Drug-induced oral adverse effects and their clinical management.
9. Epidemiology, Public Health, and Global Oral Health
• Global burden of oral diseases and their intersection with systemic health priorities.
• Epidemiological studies examining oral health determinants, disparities, and population-level trends.
• Health policy, access to care, and integration of oral health within primary healthcare systems.
10. Clinical Medicine and Dentistry Integrated Practice
• Interdisciplinary clinical case studies illustrating medical-dental integration.
• Pre-operative dental assessment and optimisation in medical and surgical patients.
• Anaesthetic, sedation, and pain management considerations at the medical-dental interface.